Cognitive Functions in Patients With Multiple Sclerosis

Status Completed

Clinical Trial Summary

Approximately 65% of multiple sclerosis (MS) patients appear to have problems in their cognitive function. Long-term memory is one of the most frequently affected functions in MS patients. Many factors play a role in the deterioration of cognitive functions because of many symptoms of MS.

The aim of this study is to investigate the relationship of cognitive function with physical factors such as balance, functional exercise capacity and personal factors such as fatigue level, mood, sleep quality in patients with MS.

Clinical Trial Description

Patients with MS between 0-5,5 score according to the Extended Disability Status Scale (EDSS) and healthy individuals of similar age and sex to patients will be included in the study. The cognitive function, balance, functional exercise capacity, fatigue, mood, sleep quality will be evaluated once.

Investigators will use descriptive statistics and t-tests to compare variables between groups. Investigators will examine the correlations between variables using Pearson bivariate correlations. The significance level is set at p<0,05. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03594357
Study type	Observational
Source	Gazi University
Contact
Status	Completed
Phase
Start date	September 3, 2018
Completion date	December 24, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03608527` - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis	N/A
Completed	`NCT02486640` - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed	`NCT01324232` - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis	Phase 2
Completed	`NCT04546698` - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting	`NCT04380220` - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed	`NCT02835677` - Integrating Caregiver Support Into MS Care	N/A
Completed	`NCT03686826` - Feasibility and Reliability of Multimodal Evoked Potentials
Completed	`NCT03653585` - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting	`NCT04798651` - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis	N/A
Recruiting	`NCT05054140` - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis	Phase 2
Completed	`NCT04147052` - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis	N/A
Completed	`NCT03591809` - Combined Exercise Training in Patients With Multiple Sclerosis	N/A
Recruiting	`NCT05208840` - A Study To Determine The Effect Of Ocrelizumab On Leptomeningeal Inflammation In Multiple Sclerosis	Phase 4
Completed	`NCT03269175` - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies	Phase 4
Completed	`NCT02845635` - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
Completed	`NCT02232061` - Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks	Phase 4
Recruiting	`NCT04990219` - A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis	Phase 1
Recruiting	`NCT03983681` - Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS	N/A
Enrolling by invitation	`NCT04676204` - Relationship Between Oral DMT Burden and Adherence in MS
Recruiting	`NCT03424733` - Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects	Phase 4